Alimera Sciences Price History

ALIMDelisted Stock  USD 5.54  0.01  0.18%   
If you're considering investing in Alimera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alimera Sciences stands at 5.54, as last reported on the 4th of January, with the highest price reaching 5.56 and the lowest price hitting 5.53 during the day. We have found thirty technical indicators for Alimera Sciences, which you can use to evaluate the volatility of the firm. Please confirm Alimera Sciences' Mean Deviation of 2.74, risk adjusted performance of 0.1195, and Downside Deviation of 1.82 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Alimera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ALIM
Based on monthly moving average Alimera Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alimera Sciences by adding Alimera Sciences to a well-diversified portfolio.

Alimera Sciences Stock Price History Chart

There are several ways to analyze Alimera Stock price data. The simplest method is using a basic Alimera candlestick price chart, which shows Alimera Sciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Alimera Stock Price History Data

The price series of Alimera Sciences for the period between Sun, Oct 6, 2024 and Sat, Jan 4, 2025 has a statistical range of 2.7 with a coefficient of variation of 15.33. The prices are distributed with arithmetic mean of 5.26. The median price for the last 90 days is 5.56. The company had 1:15 stock split on 15th of November 2019. Alimera Sciences issued dividends on 2019-11-15.
OpenHighLowCloseVolume
01/04/2025
 5.55  5.56  5.53  5.54 
09/13/2024 5.55  5.56  5.53  5.54  2,678,474 
09/12/2024 5.54  5.57  5.54  5.55  705,891 
09/11/2024 5.53  5.56  5.52  5.53  2,108,668 
09/10/2024 4.66  5.29  4.32  5.19  8,673,728 
09/09/2024 5.56  5.57  5.53  5.55  1,587,731 
09/06/2024 5.55  5.63  5.54  5.56  9,087,900 
09/05/2024 5.56  5.56  5.53  5.54  1,187,355 
09/04/2024 5.53  5.56  5.52  5.54  1,654,415 
09/03/2024 5.55  5.56  5.51  5.52  1,028,959 
08/30/2024 5.56  5.57  5.53  5.53  1,103,130 
08/29/2024 5.57  5.58  5.53  5.54  2,257,947 
08/28/2024 5.59  5.59  5.55  5.55  751,326 
08/27/2024 5.59  5.60  5.58  5.59  268,393 
08/26/2024 5.60  5.60  5.59  5.60  165,131 
08/23/2024 5.59  5.60  5.58  5.59  210,554 
08/22/2024 5.59  5.60  5.58  5.58  95,865 
08/21/2024 5.60  5.60  5.58  5.59  65,688 
08/20/2024 5.60  5.60  5.58  5.58  77,726 
08/19/2024 5.58  5.62  5.58  5.59  162,796 
08/16/2024 5.57  5.60  5.57  5.58  38,644 
08/15/2024 5.60  5.60  5.58  5.58  86,810 
08/14/2024 5.59  5.59  5.58  5.59  64,304 
08/13/2024 5.59  5.60  5.58  5.60  109,373 
08/12/2024 5.60  5.60  5.57  5.60  83,931 
08/09/2024 5.57  5.59  5.56  5.59  94,069 
08/08/2024 5.55  5.57  5.54  5.57  136,994 
08/07/2024 5.56  5.56  5.54  5.55  106,244 
08/06/2024 5.54  5.57  5.53  5.55  204,449 
08/05/2024 5.55  5.57  5.52  5.55  221,328 
08/02/2024 5.56  5.57  5.56  5.56  149,027 
08/01/2024 5.56  5.57  5.56  5.56  332,070 
07/31/2024 5.56  5.58  5.56  5.56  135,141 
07/30/2024 5.57  5.57  5.54  5.55  280,454 
07/29/2024 5.57  5.58  5.55  5.56  2,101,473 
07/26/2024 5.60  5.60  5.56  5.57  1,337,664 
07/25/2024 5.59  5.60  5.57  5.59  217,743 
07/24/2024 5.58  5.60  5.57  5.59  104,625 
07/23/2024 5.57  5.60  5.57  5.60  76,262 
07/22/2024 5.56  5.58  5.56  5.58  84,488 
07/19/2024 5.58  5.58  5.56  5.57  99,558 
07/18/2024 5.56  5.59  5.56  5.58  113,321 
07/17/2024 5.56  5.58  5.56  5.56  88,313 
07/16/2024 5.58  5.60  5.56  5.58  114,874 
07/15/2024 5.58  5.62  5.56  5.56  125,411 
07/12/2024 5.58  5.60  5.56  5.60  247,203 
07/11/2024 5.57  5.60  5.56  5.56  156,402 
07/10/2024 5.54  5.58  5.53  5.56  307,522 
07/09/2024 5.54  5.55  5.52  5.53  464,249 
07/08/2024 5.54  5.56  5.53  5.54  109,594 
07/05/2024 5.53  5.55  5.52  5.55  282,342 
07/03/2024 5.52  5.54  5.52  5.52  267,732 
07/02/2024 5.52  5.53  5.52  5.52  189,082 
07/01/2024 5.55  5.55  5.52  5.52  260,428 
06/28/2024 5.53  5.56  5.53  5.56  2,910,318 
06/27/2024 5.52  5.54  5.52  5.53  307,756 
06/26/2024 5.52  5.54  5.51  5.52  486,762 
06/25/2024 5.55  5.57  5.51  5.52  2,343,779 
06/24/2024 5.55  5.65  5.53  5.54  7,226,884 
06/21/2024 3.05  3.22  3.05  3.15  121,196 
06/20/2024 3.05  3.11  3.01  3.05  96,630 

About Alimera Sciences Stock history

Alimera Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alimera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alimera Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alimera Sciences stock prices may prove useful in developing a viable investing in Alimera Sciences
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 145 people.

Alimera Sciences Stock Technical Analysis

Alimera Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Alimera Sciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alimera Sciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Alimera Sciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Alimera Sciences' price direction in advance. Along with the technical and fundamental analysis of Alimera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alimera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Alimera Stock

If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets